The Insider Meet the Fund Manager Biotech

The Insider

Biotech Special Event

The Insider: Biotech Special Event session is an interactive panel discussion featuring industry leaders providing valuable insights on biotech investing basics, how the sector fits into the current market, investment trends and how to identify potential opportunities.

Matt McNamara

Horizon 3 Biotech

Steven Yatomi-Clarke

Prescient Therapeutics

21st July, 2022


Matt unravels why he believes investing in later-stage companies yields better results and Steven weighs in with his views on the role of technology in biotech. Also, learn what investors without biotech experience can expect from investing in the sector.

21st July, 2022

Matt explains how Horizon 3 Biotech’s ‘Achilles Heel’ investment approach and the company’s specialised team narrow down high-potential biotechs, and Steven talks about the challenges of investing in an ‘opaque’ industry with many price imperfections.

21st July, 2022

Patrick, Steven and Matt discuss current biotech investment trends, including which emerging segments and technologies are attracting the most investment capital, and mention an exciting inter-industry convergence with huge investment potential.

21st July, 2022

Like these investment ideas? Join our next session to discover more like this by clicking here

Steven explains how Prescient has set itself up to succeed in healthcare’s largest sector, the unique advantages of Prescient’s positioning in the industry and how the company’s technologies and business model complement its positioning.

21st July, 2022

Matt reveals five key stocks in Horizon 3 Biotech’s wholesale portfolio and provides rationale for why they fit into the fund’s investment philosophy. He also talks about the companies’ key advantages, target markets and how they are faring in the current market environment.

21st July, 2022


Register your details

By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement. Reach Markets are the advisors assisting with the management of this offer and may receive fees depending on whether an offer is taken up by investors.

Meet the Fund Manager

Upcoming Session

Register for an Upcoming Webcast

This exclusive event gives investors unprecedented access to Australia’s leading fund managers to hear about their favourite companies, unique market insights, and the opportunity to ask questions.

This is an opportunity to hear from Matt McNamara, CIO & Board Director at Horizon3 Healthcare.

Join Matt to learn about:

  • His three favourite stocks of the moment
  • Investment strategy and approach
  • Market outlook

This is a live and interactive online session, and participants are encouraged to ask questions. Spots are limited, so secure yours today.

Book into the next session

What is a 708 investor?

By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.

Past Sessions

Martin Pretty Equitable Investors

Martin Pretty gained vast financial experience as an investment manager at Thorney Investment Group, helping deliver one of the group’s highest annualised three-year returns (18.2% per annum) as at February 2017. He is the director of several ASX-listed companies and as a financial journalist has contributed to the Australian Financial Review and other reputable publications.

Luke Winchester Merewether Capital

Luke Winchester, managing director and CIO at Merewether Capital, started the company with the goal of building a reputation as one of the leading small and microcap managers in the Australian equities market and is one of the largest investors in the Merewether Capital Inception Fund.

Harley Grosser Capital H Management

Harley Grosser, founder and managing director, founded Capital H Management in 2014 having previously worked for Pie Funds and Bligh Capital. He has been investing in ASX-listed small caps for 12 years and is also the managing director of Australian Rural Capital and non-executive director of Motio.

*Past performance is not a reliable indicator of future performance.
** Reach does not assume responsibility for the accuracy or completeness of any information provided, and the views expressed are not reflective of Reach Markets position. Any advice contained within this presentation is general advice and does not consider your personal circumstance, you should consider whether it’s appropriate for you. The information we are giving you is for educational purposes only. “Investing is about understanding your risk” and every time you invest in the share market there is a risk of loss. If you are thinking about acquiring a financial product, you should read any relevant Product Disclosure Statement, disclosure documents and Target Market Determination (TMD) available from the issuer.

Reach Markets

Reach Markets Pty Ltd - ABN 36 145 312 232

Is a Corporate Authorised Representative (CAR No:431191) of:

Reach Financial Group Pty Ltd - ABN 17 090 611 680 AFSL Number 333297

Level 7, 440 Collins Street, Melbourne 3000, Australia

T: 1300 80 57 95    


Neori theme, designed by litMotion Templates